Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 49.38 8.05%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics Operating Income 2011-2024 | HALO

Annual Operating Income Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
338 M 268 M 276 M 144 M -67.6 M -69.3 M 81 M -83.2 M -27.5 M -63 M -80.4 M -53.6 M -19.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
338 M -83.2 M 49.4 M

Quarterly Operating Income Halozyme Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
163 M 117 M 95.5 M - 88.3 M 94.5 M 53.8 M - 83.3 M 34.1 M 75.7 M - 75.6 M 93 M 50.7 M - 40.3 M 29.6 M -3.22 M - -24.5 M -14 M 2.97 M - -25.5 M -20.1 M -23.7 M - 8.08 M -25.5 M -27.5 M - -22.7 M -21.7 M -16.2 M - -23.2 M 4.23 M -13.9 M - -19 M -14.9 M -25.2 M - -18.5 M -22.1 M -18.5 M - -20 M -14 M -15.1 M - 5.15 M 3.1 M -9.66 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
163 M -27.5 M 16.2 M